DeSimone Jill 4
4 · iTeos Therapeutics, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-11+24,200→ 24,200 totalExercise: $16.32From: 2025-06-11Exp: 2034-06-11→ Common Stock (24,200 underlying)